Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100129964 | 10012996 | 4 | F | 20140306 | 20140624 | 20140314 | 20140630 | PER | US-PFIZER INC-2014070440 | PFIZER | 64.00 | YR | M | Y | 0.00000 | 20140630 | N | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100129964 | 10012996 | 1 | PS | Xalkori | 1 | 200 MG, 2X/DAY | D | 202570 | 200 | MG | CAPSULE | BID | |||||||
| 100129964 | 10012996 | 2 | SS | Xalkori | 1 | 250 MG, 2X/DAY | D | 202570 | 250 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100129964 | 10012996 | 1 | Lung neoplasm malignant |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100129964 | 10012996 | Diarrhoea | |
| 100129964 | 10012996 | Eczema | |
| 100129964 | 10012996 | Nausea | |
| 100129964 | 10012996 | Oropharyngeal pain | |
| 100129964 | 10012996 | Peripheral swelling | |
| 100129964 | 10012996 | Throat irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100129964 | 10012996 | 1 | 20140215 | 0 |